Answers are grounded in this paper and cite their sources.
This research shows NRG-1 boosts axonal growth via the ITGB1/FAK/AKT pathway in diabetic rats, suggesting therapeutic avenues.
Objectives: The purpose of this study was to investigate the role of the ITGB1/FAK/AKT pathway in NRG‐1 in mediating the axonal growth of dorsal root ganglion neurons in Type I diabetic rats and to explore the mechanism of neuronal axonal regeneration. Result: The effects of NRG‐1 on neurite outgrowth in diabetic rats were determined by protein quantification and axon length analysis in which axons were identified with tubulin‐ β III‐specific staining. Western blot showed that the signaling activity of the ITGB1/FAK/AKT pathway was decreased in diabetic rats compared with normal rats, and exogenous NRG‐1 significantly promoted axonal growth and activated the pathway. After the addition of ITGB1‐specific siRNA, the axonal growth–promoting effect of NRG‐1 was partially reversed. Conclusion: NRG‐1 promotes axonal outgrowth in diabetic DRGs via upregulating the ITGB1/FAK/AKT pathway, providing a potential target for diabetic neuropathy.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: